Inhibrx Biosciences, Inc

This study tests an experimental drug called INBRX-109 in people with a rare bone cancer (conventional chondrosarcoma) that cannot be removed by surgery or has spread. About 206 participants will receive either the drug or a placebo to see if it slows tumor growth and improves su…

This study tests whether adding an experimental drug (INBRX-106) to a standard immunotherapy (pembrolizumab) works better than the standard drug alone for people with advanced head and neck cancer that has spread or come back. About 410 adults whose tumors have a specific marker …

This study tests a new experimental drug called INBRX-106, given alone or with the immunotherapy pembrolizumab (Keytruda), in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find the safest dose and to see if the combin…